Skip to content

The Role of the Pan-Immun-Inflammatory-Value Index in Predicting Hospital Stay Duration in Patients with Myocarditis

The Role of the Pan-Immun-Inflammatory-Value Index in Predicting Hospital Stay Duration in Patients with Myocarditis

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20240706008
Enrollment
200
Registered
2024-07-06
Start date
2024-07-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A cross-sectional study will be conducted in myocarditis patients Myocarditis, Pan-immun-inflammatory-value index, Hospitalization Time

Interventions

PIV in patients with myocarditis
Treatment
study group

Sponsors

Beyhekim Research and Training Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Additional data were retrieved from the hospital's electronic medical record system. Follow-up information on major cardiac events at 1 and 6 months post-discharge was obtained through the national health information system (www.enabiz.gov.tr) and by contacting patients via their registered phone numbers

Exclusion criteria

Exclusion criteria: Patients who were not treated in our clinic, those with incomplete information during file review, and those whose data could not be accessed were excluded from the study.

Design outcomes

Primary

MeasureTime frame
sample size before determining the number of samples pan-immun-inflamatory index

Secondary

MeasureTime frame
hemogram only one blood analysis

Countries

Turkey

Contacts

Public ContactAzmi Eyiol

Beyhekim Research and Training Hospital

azmieyiol@gmail.com095354792463

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026